Cargando…
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy that often presents clinically at an advanced stage and that may be confused with chronic pancreatitis (CP). Conversely, CP may be misdiagnosed as PDAC leading to unwarranted pancreas resection. Therefore, early PDAC diagnosis and clear...
Autores principales: | Lai, Xianyin, Wang, Mu, McElyea, Samantha Deitz, Sherman, Stuart, House, Michael, Korc, Murray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386003/ https://www.ncbi.nlm.nih.gov/pubmed/28232049 http://dx.doi.org/10.1016/j.canlet.2017.02.019 |
Ejemplares similares
-
Label-Free Nanoplasmonic-Based Short Noncoding RNA Sensing at Attomolar Concentrations Allows for Quantitative and Highly Specific Assay of MicroRNA-10b in Biological Fluids and Circulating Exosomes
por: Joshi, Gayatri K., et al.
Publicado: (2015) -
Highly Specific Plasmonic Biosensors for Ultrasensitive
MicroRNA Detection in Plasma from Pancreatic Cancer Patients
por: Joshi, Gayatri K., et al.
Publicado: (2014) -
A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile
por: Cote, Gregory A, et al.
Publicado: (2014) -
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
por: Frampton, Adam E., et al.
Publicado: (2018) -
Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes, Not in the Microvesicles
por: Koksal, Ali Riza, et al.
Publicado: (2022)